Tau protein is crucial in Alzheimer’s disease and dementia as it plays a central role in neurodegeneration. In Alzheimer’s, tau proteins malfunction, forming twisted tangles inside brain cells called neurofibrillary tangles. These tangles disrupt the cell's transport system, leading to the death of neurons and contributing to cognitive decline and memory loss characteristic of the disease. Research indicates that tau pathology correlates closely with cognitive impairment in Alzheimer’s patients, making it a significant target for therapeutic interventions. Understanding how tau proteins aggregate and spread throughout the brain is crucial for developing treatments that can slow or halt the progression of Alzheimer’s disease and other forms of dementia associated with tau pathology. Therefore, ongoing research focuses on elucidating tau's role in neurodegeneration to devise effective strategies for combating these devastating conditions.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China